lyzer identified the A2058G and A2059G mutations. The percentage of specimens with either the A2058G or A2059G mutation was 100% (66/66). The A2058G mutation was detected in 61/66 (92.4%) specimens, while the A2059G mutation was detected in 5/66 (7.6%) specimens. The latter mutation was detected in specimens collected in 2011 (3/24) and in 2012 (2/38), suggesting that it has been present for at least 3 years. This report identifies, for the first time in China, the existence of strains containing the A2059G mutation. The extremely high prevalence of macrolide-resistant T. pallidum in Shandong may be related to the extensive use of the antibiotics in clinical treatment. Macrolides have been widely used for the treatment of respiratory diseases, skin infections, and sexually transmitted disease infections in China, providing the background for the development of macrolide resistance.
In summary, we found a high prevalence of azithromycin-resistant T. pallidum in Shandong, which is consistent with the findings in different areas in China (4, 15) and suggested that currently circulating T. pallidum strains in Taiwan may be unrelated to those in mainland China. We report the presence of two mutations in the 23S rRNA gene of T. pallidum, which further expands our knowledge of the geographical distribution of these strains.
